⌘K
Loading ticker…
As of 2026-08-24, Stepan Co. (SCL) has a 3-month relative strength percentile of 80 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 57. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.9%, relative volume 0.59×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
SCL is in a stage 2 uptrend, week 12. Currently in a 127-day base; basing ADR 3.1% (broad 2.6%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 4.8% / 17.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SCL is held by 35 ETFs as of May 2026. Top owner: AVUV at 0.14% weight, $39M notional. Top 3 carry $55M.
Held by 84 ETFs · $349M across latest filings · largest weight 1.95% (TCV).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.14% | $39M | +0.02 pp |
| FNDA | 0.11% | $9M | −0.01 pp |
| SMDV | 1.05% | $7M | +0.03 pp |
| VTWO | 0.03% | $6M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.02% | $5M | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.07% |
| $4M |
| — |
| VAWVanguard Materials ETF | 0.07% | $3M | — |
| RWJ | 0.16% | $3M | — |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.13% | $2M | — |
| AVSC | 0.08% | $2M | −0.02 pp |
Showing 10 of 35 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SCL Jan avg: 4.30% median: 0.57% win: 50% σ: 12.11% n: 4 2022-04-12 → 2026-07-31 | SCL Feb avg: -4.89% median: -3.90% win: 0% σ: 4.98% n: 4 2022-04-12 → 2026-07-31 | SCL Mar avg: -3.19% median: -1.40% win: 25% σ: 5.26% n: 4 2022-04-12 → 2026-07-31 | SCL Apr avg: -4.48% median: -7.83% win: 40% σ: 6.19% n: 5 2022-04-12 → 2026-07-31 | SCL May avg: 5.51% median: 5.64% win: 80% σ: 3.72% n: 5 2022-04-12 → 2026-07-31 | SCL Jun avg: -0.68% median: 0.53% win: 60% σ: 6.09% n: 5 2022-04-12 → 2026-07-31 | SCL Jul avg: 3.98% median: 0.80% win: 80% σ: 8.85% n: 5 2022-04-12 → 2026-07-31 | SCL Aug avg: -6.44% median: -7.69% win: 0% σ: 3.41% n: 4 2022-04-12 → 2026-07-31 (current) | SCL Sep avg: -7.34% median: -7.39% win: 0% σ: 5.99% n: 4 2022-04-12 → 2026-07-31 | SCL Oct avg: -1.05% median: -3.29% win: 25% σ: 9.15% n: 4 2022-04-12 → 2026-07-31 | SCL Nov avg: 7.02% median: 6.57% win: 100% σ: 2.44% n: 4 2022-04-12 → 2026-07-31 | SCL Dec avg: -0.36% median: -0.05% win: 50% σ: 12.95% n: 4 2022-04-12 → 2026-07-31 |